GlaxoSmithKline and Johnson & Johnson will become pharma partnering for increasing production of an Ebola vaccine, with an aim to produce at least 1 million doses next year. Read the full story

Aduro Biotech just inked a pharma deal with the Johnson & Johnson Innovation Center in California to help it develop its nascent lung cancer therapies. Read the full story

Johnson & Johnson announced that it has officially acquired Alios BioPharma for $1.7 billion in cash. Read the full story

Johnson & Johnson is a top pharmaceutical company based in New Brunswick NJ, USA Read the full story

Smith & Nephew Plc’s M&A bid for ArthroCare, at the lowest premium for a medical-instruments company since the 1990s, is giving Stryker or Johnson & Johnson a shot at a rival offer Read the full story

Johnson & Johnson agrees to pay a settlement of $2.2 billion for a dispute of over 8 years.

Read the full story

According to dealtalk, Abbott Laboratories is presently evaluating an asset purchase transaction, whereby, it may acquire certain assets of Johnson & Johnson in Pakistan. Read the full story

In dealtalk, Johnson & Johnson launched a sale process for its Ortho Clinical Diagnostics unit for around $5 billion. Read the full story

Johnson & Johnson is joining the hunt for drugs to treat dengue fever - the world's fastest-spreading tropical disease - by entering pharma deals with academic researchers in Belgium and the Wellcome Trust medical charity. Read the full story

Johnson & Johnson / Janssen has also announced over 16 M&A deals since 2005, with the lead deals being the acquisition of Synthes, Crucell and Mentor Read the full story